Tech Company Financing Transactions

US Biologic Funding Round

US Biologic closed a $625 thousand funding round on 12/31/2014. Investors included LaunchTN.

Transaction Overview

Company Name
Announced On
12/31/2014
Transaction Type
Venture Equity
Amount
$625,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
20 Dudley 900
Memphis, TN 38103
USA
Email Address
Overview
US BIOLOGIC's proprietary oral-delivery system is changing global disease prevention. Our technology allows safe, effective, and cost-efficient delivery of a variety of preventative therapeutics (vaccine and medicine) to wildlife, companion animals, and food animals.
Profile
US Biologic LinkedIn Company Profile
Social Media
US Biologic Company Twitter Account
Company News
US Biologic News
Facebook
US Biologic on Facebook
YouTube
US Biologic on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Mason Kauffman
  Mason Kauffman LinkedIn Profile  Mason Kauffman Twitter Account  Mason Kauffman News  Mason Kauffman on Facebook
Chief Scientific Officer
Steve Zatechka
  Steve Zatechka LinkedIn Profile  Steve Zatechka Twitter Account  Steve Zatechka News  Steve Zatechka on Facebook
Executive Vice President
Chris Przybyszewski
  Chris Przybyszewski LinkedIn Profile  Chris Przybyszewski Twitter Account  Chris Przybyszewski News  Chris Przybyszewski on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2014: Urgent Team Holdings venture capital transaction
Next: 12/31/2014: Personalis venture capital transaction

 

Share this article

 


About Database of VC Transactions

We report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary